IQST
iQSTELCAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
The fresh primary-source set improves confidence in the facts but not in the forward thesis. The 10-K and April 2026 earnings materials confirm revenue growth, better gross margin, stronger equity, and no year-end convertible notes outstanding, yet they also confirm operating cash burn and an unresolved going-concern warning [#10-K-2026-04-06][#8-K-2026-04-10]. Combined with the deterministic score turning negative and catalyst density dropping, this reads as a cautious monitoring setup rather than a high-conviction bullish turn.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The next quarterly filing is the clearest near-term test of whether FY2025 revenue growth to $316.9M, gross profit of $9.46M, positive working capital of $1.56M, and year-end cash of $2.16M are translating into cleaner cash conversion and reduced financing dependence. This matters because the FY2025 10-K still states substantial doubt about the company’s ability to continue as a going concern despite operational progress [#10-K-2026-04-06].
In the April 7, 2026 earnings-call transcript furnished with the April 10, 2026 8-K, management said it was "really excited about the launch of cybersecurity in 40 days" and also planned to launch digital-health services, positioning both as higher-margin add-ons to its 600-plus operator platform. A concrete launch with early customer proof would help validate the EBITDA-expansion narrative; a vague rollout would reinforce that the new-vertical thesis is still mostly promotional [#8-K-2026-04-10].
Management said on the April 7, 2026 earnings call that it had two acquisitions on the radar, one already negotiated, and a goal to reach a $50M EBITDA run rate this year, while also moving more of the operating businesses onto a single platform. That upside case is meaningful, but it must be weighed against the audited FY2025 record of continued operating cash burn, high-cost loans, and a going-concern warning. The stock likely needs filed evidence of accretive deals and sustained profitability before a durable rerating can hold [#8-K-2026-04-10][#10-K-2026-04-06].
Recommendation
No formal recommendation provided.

